Description

TESAMORELIN

Tesamorelin is a synthetic 44-amino-acid analog of human growth hormone-releasing factor (GHRF), modified at the N-terminus. This research peptide is useful for examining growth hormone-releasing hormone receptor activation, intracellular cAMP signaling, and growth hormone/IGF-1 pathway regulation in appropriate experimental systems.

RESEARCH

Tesamorelin is provided for in vitro laboratory research into peptide-receptor interactions and downstream endocrine signaling. Its pharmacology as a GHRH analog is established, and prescription Tesamorelin exists in separately regulated pharmaceutical formulations; this Revyon research reagent is not a prescription product and is not intended for therapeutic use.

CHEMICAL INFORMATION

• Molecular Formula (free base): C221H366N72O67S
• Molecular Weight: 5135.86 Da
• CAS Number: 218949-48-5

RESEARCH APPLICATIONS

• GHRH Receptor Research: Examine receptor binding and activation in validated assay systems.
• Second-Messenger Signaling: Study cAMP and related intracellular responses following receptor activation.
• GH/IGF-1 Axis: Investigate hormonal regulation using appropriate research models.
• Structure–Activity Relationships: Explore the role of peptide modification in signaling and stability.

STORAGE AND HANDLING

• Store lyophilized powder at -20°C, subject to product-specific stability data.
• After reconstitution, follow a validated laboratory stability protocol and use promptly.
• Protect from direct sunlight and avoid repeated freeze-thaw cycles.
• Maintain aseptic techniques during laboratory handling to minimize contamination.

PRODUCT SPECIFICATION

• Purity:  ≥99% (HPLC)
• Appearance:  Lyophilized white powder
• Solubility: Soluble in sterile water or appropriate aqueous laboratory buffers.

COMPLIANCE NOTICE

Tesamorelin (10 mg) is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. This research product is not to be used for therapeutic, diagnostic, or clinical purposes. By purchasing this product, buyer represents and warrants that it will be used only for in vitro research purposes.

BENEFITS BEING RESEARCHED

• Growth hormone-releasing hormone receptor activation
• cAMP-associated intracellular signaling
• Growth hormone secretion pathways in appropriate models
• IGF-1-associated endocrine regulation
• Peptide structure–activity and receptor selectivity
• Feedback regulation in the GH/IGF-1 axis

MECHANISM OF ACTION (Simplified)

• Receptor Interaction: Tesamorelin acts as a GHRH receptor agonist.
• Second Messenger: Receptor activation can stimulate adenylyl cyclase/cAMP signaling.
• Hormonal Signaling: In relevant models, GHRH receptor activation promotes pituitary growth hormone release and downstream IGF-1 signaling.
• Overall research focus = receptor pharmacology and endocrine signaling mechanisms.

FORM / NOTES

Lyophilized vial containing 10 mg of Tesamorelin for controlled laboratory preparation.
Confirm acetate/salt form, solubility, storage, and stability with batch documentation. Not intended for human or animal use.

LEGAL DISCLAIMER

This product is sold strictly for laboratory research use only.

By purchasing this product, the buyer represents and warrants that:

• The material will be used solely for in-vitro research purposes
• The buyer is qualified to handle laboratory reagents
• The product will not be used for human or animal consumption, injection, or application

Revyon Technologies assumes no liability for misuse or improper handling.

IMPORTANT NOTICE

Any use outside of stated research purposes is strictly prohibited.